StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) stock

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.10−0.05 (-2.33%)

Close on Nov 17, 2026Market cap $115.02MP/E –Yield –

Upstream Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Upstream Bio's price to sales ratio was 55.5× on Nov 11, 2026, against 357.7× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202655.5×−316.1
2025Sep 30, 2025371.6×+349.1
2024Dec 31, 202422.5×–

More Upstream Bio figures

See a number that looks wrong?